We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RNXT market cap is 36.91M. The company's latest EPS is USD -0.2412 and P/E is -4.06.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 43k |
| Operating Income | -1.78M | -2.48M | -3.03M | -2.83M | -2.63M |
| Net Income | -3.23M | -1.08M | -2.39M | -2.47M | -2.88M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 43k |
| Operating Income | -3.2M | -5.67M | -9.95M | -11.4M | -10.97M |
| Net Income | -3.8M | -6.32M | -9.89M | -10.23M | -8.81M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.47M | 4.79M | 12M | 10.03M | 8.12M |
| Total Liabilities | 4.47M | 3.02M | 2.73M | 2.96M | 3.64M |
| Total Equity | -3M | 1.77M | 9.27M | 7.07M | 4.48M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.91M | 16.29M | 7.27M | 1.47M | 8.12M |
| Total Liabilities | 4.12M | 938k | 1.1M | 4.47M | 3.64M |
| Total Equity | -14.66M | 15.35M | 6.16M | -3M | 4.48M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.26M | -2.2M | -4.5M | -6.7M | -9.13M |
| Investing | 2.03M | N/A | N/A | N/A | -12k |
| Financing | 5.01M | 5.42M | 15.07M | 15.09M | 15.12M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.53M | -5.92M | -8.81M | -10.26M | -9.13M |
| Investing | N/A | -15k | -2.03M | 2.03M | -12k |
| Financing | 3.2M | 19.33M | 42k | 5.01M | 15.12M |
| Market Cap | 36.91M |
| Price to Earnings Ratio | -4.06 |
| Price to Sales Ratio | 816.67 |
| Price to Cash Ratio | 5.01 |
| Price to Book Ratio | 8 |
| Dividend Yield | - |
| Shares Outstanding | 36.55M |
| Average Volume (1 week) | 112.92k |
| Average Volume (1 Month) | 120.93k |
| 52 Week Change | -18.22% |
| 52 Week High | 1.6899 |
| 52 Week Low | 0.75 |
| Spread (Intraday) | 0.02 (1.96%) |
| Company Name | RenovoRx Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.renovorx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
